Company intelligence / Profile preview
Pacira BioSciences
Tampa, Florida, United Statespacira.com ↗
- Ownership
- Public · PCRX
- Employees
- ~790
- Development stage
- Other
01
Overview
Pacira has three commercial-stage non-opioid therapies—EXPAREL® (bupivacaine liposome injectable suspension), ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), and iovera° system (cryoanalgesia device). EXPAREL remains a market leader in postsurgical non-opioid analgesia, with new patents extending protection into the mid-2040s. The company also received RMAT designation from the FDA in March 2024 for its gene therapy candidate PCRX‑201 targeting osteoarthritis, indicating promising early clinical results.
- Therapeutic areas
- NeurologyRheumatology
- Modalities
- Small molecules (e.g., bupivacaine liposome injectable suspension)Extended-release injectables (e.g., triamcinolone acetonide extended-release)Cryoanalgesia device technologyGene therapy vectors
- Industry
- Biotech
02
Drug pipeline
44 assets43 more assets in the full pipeline.
03
Partnerships
– Aratana Therapeutics, Inc.: development/commercialization of NOCITA for veterinary use– Premier Inc.: brand pharmaceuticals agreement
04
Financials
- Market cap
- $1.5B
- Total revenue
- $726.4M
- Enterprise value
- $1.2B
Beyond the preview
Go deeper on Pacira BioSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pacira BioSciences.